Devyn Smith

CEO Arbor Bio Gene Editing Company. Focus on curative therapies for patients with genetic diseases.

[Devyn Smith @devynsmith15]

@yaireinhorn @arbortx @zhangf @MayoClinic Thanks for the call out. Proud to be first next gen CRISPR company in the clinic

[Devyn Smith @devynsmith15]

Pleased to add some key technology and assets from Serendipity.

[Arbor Biotechnologies @arbortx]

In @endpts today: CEO @devynsmith15 discusses our acquisition of Serendipity. Its nuclease technologies, discovered in @zhangf’s lab, will expand our toolbox of novel, next-gen editors.

https://t.co/gvtBvP7l47

[Devyn Smith @devynsmith15]

Excited to work with @AllogeneTx together on next gen cell therapy for autoimmune disease!

[Arbor Biotechnologies @arbortx]

We are delighted to announce our new licensing agreement with @AllogeneTx. Our proprietary CRISPR #geneediting technology will be used to develop Allogene’s next generation AlloCAR T platform for the treatment of #autoimmunedisease.

Read more: https://t.co/5ua3R3spp9

[Devyn Smith @devynsmith15]

Happy to partner our next gen editing approaches with @4DMolecular next gen capsids for CNS diseases

[Arbor Biotechnologies @arbortx]

We are excited to announce a new partnership with 4D Molecular Therapeutics. Through our complementary technologies, we aim to advance our shared mission and help develop new CNS therapies.

Read more at https://t.co/Ylkxt1ifSs
#CRISPR #GeneEditing #GeneticMedicine #biotech

[Arbor Biotechnologies @arbortx]

Arbor CEO @devynsmith15 reflects on 2023.

What do you most look forward to in 2024?

#CRISPR #biotech #GeneEditing

[Devyn Smith @devynsmith15]

Enjoyed my conversation with PharmaVoice about Arbor.

[Arbor Biotechnologies @arbortx]

ICYMI: CEO @devynsmith15 speaks with @PharmaVoice about Arbor’s expanded toolbox of #geneediting technologies to tackle #CNS and liver diseases.

Read more here: https://t.co/kTVwnZOOIY

[Arbor Biotechnologies @arbortx]

We’re honored to welcome Nolan to welcome our Board of Directors. His knowledge and experience will be invaluable as we advance our platform technologies and work to bring novel therapies to patients with high unmet need. Learn more: https://t.co/ZeQ4p65xth

[Arbor Biotechnologies @arbortx]

ICYMI: Arbor Bio CEO Devyn Smith recently joined host Jasmeet Sawhney on the Leading Minds Podcast to discuss his trajectory in the field and his view on purposefully contributing to the therapeutic landscape.
Tune in to hear more: https://t.co/RWTUWS1NQl

[Devyn Smith @devynsmith15]

A fun discussion with Tim Hunt

[Alliance for Regenerative Medicine (ARM) @alliancerm]

We've kicked off our first interviews at ARM Studios, our first-ever video booth at #CGMesa23!

Stay tuned this week as we'll share highlights and insights from our interviews with sector executives.

[Alliance for Regenerative Medicine (ARM) @alliancerm]

We’re kicking off #CGMesa23 with a big announcement! We’ve elected our 2024 Board of Directors at the conference’s opening. These distinguished individuals will be key to ARM’s leadership of the sector.

A big welcome to our new board members: https://t.co/QNhwPpdK61
1/3

[Arbor Biotechnologies @arbortx]

Interested in learning more about Arbor Bio and our extensive toolbox of proprietary genomic editors? Look for CEO Devyn Smith, CTO David Cheng, and CFO Ajim Tamboli at these October conferences. #arborbio #biotech

[Devyn Smith @devynsmith15]

Very excited that Ajim is joining Arbor as our new CFO

[Arbor Biotechnologies @arbortx]

We're pleased to announce the appointment of Ajim Tamboli as Chief Financial Officer. Ajim’s 20+ years of biotech and investment banking experience will be invaluable as we continue to strategically grow the company. Learn more: https://t.co/TIXXrhxNlT

[Devyn Smith @devynsmith15]

Pleased to have done this podcast with leading minds.

[Life Sciences Voice @LifeSciVoice]

Dr. Devyn Smith, the CEO of Arbor Biotechnologies, one the leading CRISPR gene editing companies today, joins us to discuss cutting and rewriting sections of DNA so that you can replace mutations.

#LeadingMinds #lifesciences #healthcare #Technology #ArborBiotechnologies #DrDevyn

[Devyn Smith @devynsmith15]

A great step forward in our understanding of genetic diversity

[Arbor Biotechnologies @arbortx]

This week, scientists unveiled a more accurate human genome - the Pangenome. This new map has the potential to expand our knowledge of genomic variation, advancing #geneediting approaches and leading to better therapeutics. - Arbor CEO @DevynSmith15.
https://t.co/I6EQiSQ88i

[Devyn Smith @devynsmith15]

Excited to participate with such talented leaders

[WuXi AppTec @WuXi_AppTec]

Our next #TakingBOLDAction online event is this week!

Register to learn about advances in #cellandgenetherapies from @kickassscience1, Theresa Heah, Reagan Jarvis, Phil Johnson, Paul Lammers, Peter Maag, @devynsmith15, Thomas Willemsen & Caroline Xu.
https://t.co/HEYtrSzbl1

[Devyn Smith @devynsmith15]

Excited to participate in the conference.

[Arbor Biotechnologies @arbortx]

This week, Arbor’s CEO @DevynSmith15 is participating in the Needham Virtual Healthcare Conference and will be presenting tomorrow at 9:30 a.m.

[Devyn Smith @devynsmith15]

WelcomeDan!

[Arbor Biotechnologies @arbortx]

Arbor is excited to announce the appointment of Dr. Daniel Ory as Chief Medical Officer! We welcome Dr. Ory and his experience in the rare disease space and look forward to his contributions in evolving Arbor’s pipeline development strategy. Learn more: https://t.co/lRUGekjs6f

[Arbor Biotechnologies @arbortx]

Today, Arbor announced that our CEO @DevynSmith15 will deliver welcoming remarks, participate in a panel and give a presentation at @alliancerm’s Cell & Gene Meeting on the Med later this month.

Learn more in our latest press release: https://t.co/8NxwIY9iYa #CGMed23

[Arbor Biotechnologies @arbortx]

Today we recognize the strength, achievements and contributions of women at Arbor and across the world. For International Women's Day and beyond, let's #EmbraceEquity to build an inclusive world where difference is valued and celebrated. #InternationalWomensDay2023

[Devyn Smith @devynsmith15]

Great to get back to JPM

[Arbor Biotechnologies @arbortx]

Arbor had a great week at #JPM23! Our CFO Steve Favaloro kicked it off by ringing the @Nasdaq opening bell with other #biotech execs & our CEO @devynsmith15 presented the Arbor story. We enjoyed meeting investors & colleagues and learning about new biotech innovations.